Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L)

Clinical trial NCT03894748 · COMPLETED

Trial details

NCT number: NCT03894748
Sponsor: Medy-Tox
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Glabella Line Severity

Start date: 2011-12-01
Primary completion: 2012-08-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.